Browsing by Author "Gaba, A"
Now showing items 1-2 of 2
-
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Fennell, DA; Ewings, S; Ottensmeier, C; Califano, R; Hanna, GG; Hill, K; Danson, S; Steele, N; Nye, M; Johnson, L (Elsevier, 2021-10-14)BACKGROUND: No phase 3 trial has yet shown improved survival for patients with pleural or peritoneal malignant mesothelioma who have progressed following platinum-based chemotherapy. The aim of this study was to assess the ... -
Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial
Fennell, D; Ottensmeier, C; Califano, R; Hanna, G; Ewings, S; Hill, K; Wilding, S; Danson, S; Nye, M; Steele, N (2021)